Motorola Solutions Inc vs Twist Bioscience Corp — how do they compare? Motorola Solutions Inc trades at $405.33 (market cap $68.13B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Motorola Solutions Inc is far larger — about 12.5× Twist Bioscience Corp's market cap, and Motorola Solutions Inc pays a 1.18% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MSI | TWST | |
|---|---|---|
Market Cap | $68.13B | $5.45B |
Sector | Technology | Health |
52-Week High | $490.30 | $102.88 |
52-Week Low | $363.83 | $24.16 |
Enterprise Value | $76.83B | $5.37B |
Dividend Yield | 1.18% | — |
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $406.28, down 1.7% on the day, with a bearish technical signal. The company reported strong earnings beats in recent quarters and maintains robust profitability with a 17.61% net margin and 99.88% ROE. Recent developments include the $1.5 billion acquisition of D-Fend Solutions and expansion of AI capabilities for emergency response systems, signaling strategic growth in public safety technology.
The outlook remains positive with a consensus price target of $512.33, implying 26% upside, supported by 71% analyst buy ratings. Risks include elevated valuation multiples (P/E 33.1) and significant investing cash outflows for acquisitions. The stock's near-term performance will hinge on execution of growth initiatives and Q2 2026 earnings relative to the $3.86 EPS estimate.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →